In this video, Michael Cecchini, MD, discussed data from the ALASCCA trial, which followed patients with colorectal cancer who were treated with a large dose of aspirin.

In this video, Arvind N. Dasari, MD, MS, discussed the phase 3 results from the BREAKWATER trial presented at ASCO Gastrointestinal Cancers Symposium.

Northwestern Medicine scientists have discovered that inhibiting the GATA6 protein in mouse models of colon cancer reduced ...

The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients ...

Johnson underwent a colonoscopy two weeks after running the marathon. Right after the procedure, the doctor told John that he ...

Cancer rates are rising in younger adults — what’s driving this, and how can you take preventative measures? Discover expert insights on prevention and early detection.

Trial to begin enrolling in April; expected primary completion in mid-2027 - - Primary study endpoint of rate of major pathological response - SAN DIEGO and SUZHOU, China, Feb. 27, 2025 (GLOBE NEWSWIR ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC).

For patients with stage III colon cancer, physical activity associated with attenuation of survival disparity relative to general population.

Adagene (ADAG) announced an investigator initiated Phase 2 neoadjuvant trial of ADG126 for patients with stage II or stage III colorectal ...

Trial to begin enrolling in April; expected primary completion in mid-2027 - - Primary study endpoint of rate of major ...